Alzheimer’s disease biopharma Alzamend Neuro prices 2.5M-share IPO at $5 2021-06-16T13:59:10-04:00June 16th, 2021| share this article! Alzamend Neuro (ALZN) has priced its IPO of 2.5M shares of its common stock at $5.00/share.Expected gross proceeds are $12.5M.Trading commences June 15.Underwriters’ overallotment is… Read More share this article! Related Posts Viking CEO: We are very different from big cruise lines May 1st, 2024 Viking prices IPO at $24 per share May 1st, 2024 AI will dominate both IPOs and established companies, says JC2 Ventures CEO John Chambers April 18th, 2024 Indian digital payments firm discusses IPO plans April 18th, 2024
